Breast Cancer Clinical Practice Guidelines in Oncology

2005 ◽  
Vol 3 (3) ◽  
pp. 238 ◽  
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Lung Cancer ◽  
Breast Cancer Mortality ◽  
The United States ◽  
Cancer Death ◽  
Cancer Society ◽  
The Past ◽  
Recent Version ◽  
Common Malignancy

The American Cancer Society estimates that approximately 217,440 new cases of breast cancer will have been diagnosed in the United States in the year 2004 and approximately 40,580 patients will die of this disease. Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The incidence of breast cancer has increased steadily in the United States over the past few decades, but breast cancer mortality appears to be declining. This suggests a benefit from early detection and more effective treatment. For the most recent version of the guidelines, please visit NCCN.org

NCCN Invasive Breast Cancer Clinical Practice Guidelines in Oncology

2007 ◽  
Vol 5 (3) ◽  
pp. 246 ◽  
Author(s):  
_ _
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Invasive Breast Cancer ◽  
Breast Cancer Mortality ◽  
The United States ◽  
Cancer Society ◽  
The Past ◽  
Recent Version ◽  
Common Malignancy

The American Cancer Society estimates that 214,640 new cases of breast cancer will be diagnosed and 41,430 will die of the disease in the United States in 2006. Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The incidence of breast cancer has steadily increased in the United States over the past few decades, but breast cancer mortality appears to be declining, suggesting a benefit from early detection and more effective treatment. These guidelines discuss diagnosis, treatment, and follow up for invasive breast cancer. For the most recent version of the guidelines, please visit NCCN.org

Lung Cancer

2014 ◽  
pp. 98-106
Author(s):  
Kim-Son Nguyen ◽  
Joel Neal
Keyword(s):  
United States ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
The United States ◽  
Small Cell ◽  
American Cancer Society ◽  
Cancer Death ◽  
Small Cell Lung ◽  
Cancer Society

Cancer of the lung is a group of heterogeneous malignant disorders composed of small cell lung cancer (13%), non-small cell lung cancer (NSCLC) (86%), and rare thoracic malignancies such as mesothelioma and carcinoid tumors. In 2008 the American Cancer Society estimated that 215,020 people in the United States would develop lung cancer, and 161,840 people would die of their disease. In men the age-adjusted cancer death rate for lung cancer peaked in 1990 at approximately 90 deaths per 100,000 and has since decreased to 70 per 100,000. In women, the incidence reached a plateau in 1990 at 40 per 100,000. These changes are in part due to alterations in smoking patterns, but the overall incidence of lung cancer continues to increase with the aging population. Despite the trend of decreased smoking rates in industrialized countries, lung cancer remains the leading cause of cancer death in both men and women in the United States (American Cancer Society, 2008). Lung cancer is also the leading cause of cancer death worldwide.

Lung Cancer in Women

2005 ◽  
Vol 23 (14) ◽  
pp. 3212-3218 ◽  
Author(s):  
Jyoti D. Patel
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Lung Cancer ◽  
Genetic Variation ◽  
The United States ◽  
Cancer Death ◽  
Prevention Strategies ◽  
Lung Cancer Patients ◽  
Treatment And Prevention ◽  
Biologic Factors

Lung cancer is the leading cause of cancer death in the United States and is responsible for 20,000 more deaths yearly in US women than breast cancer. Cigarette smoking is the major cause of lung cancer, and unfortunately, approximately 22 million US women smoke. Mounting evidence suggests that there are significant differences in lung cancer between the sexes. There is a difference in the histologic distribution of lung cancer, with glandular differentiation being more common in women. Genetic variation may account for differences in susceptibility, and hormonal and biologic factors may play a role in carcinogenesis. Lung cancer patients have few therapeutic options. A more thorough understanding of the heterogeneity of lung cancer across populations may lead to innovations in treatment and prevention strategies.

Breast Cancer Clinical Practice Guidelines in Oncology

2003 ◽  
Vol 1 (2) ◽  
pp. 148 ◽  
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Invasive Breast Cancer ◽  
The United States ◽  
Cancer Society ◽  
Nccn Guidelines ◽  
Recent Version

The American Cancer Society estimates that approximately 205,000 new cases of breast cancer were diagnosed in the United States in the year 2002, and approximately 40,000 patients will die of this disease. The NCCN guidelines discuss the complex and varied therapeutic options for patients with noninvasive or invasive breast cancer. For the most recent version of the guidelines, please visit NCCN.org

scholarly journals The Status of Chemotherapy in Metastatic Breast Cancer: Insights for the Advanced Practitioner

2021 ◽  
Vol 12 (2) ◽  
Author(s):  
Kirollos Hanna, PharmD, BCPS, BCOP ◽  
Kelley Mayden, MSN, FNP, AOCNP
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Metastatic Breast Cancer ◽  
Death Rate ◽  
Metastatic Breast ◽  
The United States ◽  
Cancer Society ◽  
Common Cause ◽  
Advanced Practitioner ◽  
The Status

Breast cancer is the most frequently diagnosed cancer in the United States and ranks second as the most common cause of cancer-related death among women (Siegel et al., 2020). According to American Cancer Society (ACS) estimates, approximately 276,480 new cases of breast cancer would have been diagnosed in 2020, and greater than 42,000 deaths would be attributed to breast cancer (ACS, 2020). Although only 7% of all cancer-related deaths are from breast cancer every year, it is the leading cause of death among women between the ages of 40 and 49 years (Siegel et al., 2020). The death rate associated with breast cancer, however, has decreased by 1.3% annually from 2013 to 2017.

scholarly journals 3D Printing Realistic Endobronchial Models for Surgical Planning and Simulation

2018 ◽  
Author(s):  
Zhuo Zhao ◽  
Javier Coronel Baracaldo ◽  
Juliana Palacio Varona ◽  
Roberto Rueda-Esteban ◽  
Zion Tsz Ho Tse
Keyword(s):  
United States ◽  
Lung Cancer ◽  
Death Rate ◽  
Surgical Planning ◽  
The United States ◽  
Cancer Society ◽  
Accurate Localization ◽  
Common Cancer ◽  
Detection And Diagnosis ◽  
Early Detection And Diagnosis

Lung cancer is the second most common cancer in both men and women globally. More than one million lung cancer cases are diagnosed worldwide each year. The leading cause of cancer death is lung cancer in the United States and worldwide [1]. According to the American Cancer Society, there were an estimated 222,500 new cases of lung cancer and 155,870 deaths from lung cancer in the United States in 2017. Early detection and diagnosis, as well as accurate localization in lung intervention, are the keys to reducing the death rate from lung cancer [1].

Breast Cancer Screening and Diagnosis Clinical Practice Guidelines

2006 ◽  
Vol 4 (5) ◽  
pp. 480 ◽  
Author(s):  
_ _
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Practice Guidelines ◽  
Clinical Decision Making ◽  
Cost Effective ◽  
Clinical Decision ◽  
The United States ◽  
Mammographic Screening ◽  
Effective Manner ◽  
Recent Version

The lifetime risk of a woman developing breast cancer has increased over the past 5 years in the United States: of every 7 women, 1 is at risk based on a life expectancy of 85 years. An estimated 214,640 new cases (212,920 women and 1,720 men) of breast cancer and 41,430 deaths (40,970 women and 460 men) from this disease will occur in the United States in 2006. However, mortality from breast cancer has decreased slightly, attributed partly to mammographic screening. Early detection and accurate diagnosis made in a cost-effective manner are critical to a continued reduction in mortality. These practice guidelines are designed to facilitate clinical decision making. For the most recent version of the guidelines, please visit NCCN.org

Sign in / Sign up

Export Citation Format

Share Document